Author

R. Hosea

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

H. Zhao· 1 shared I. T. S. Meliala· 1 shared M. Miyagishi· 1 shared M. Wei· 1 shared S. Hillary· 1 shared S. Wu· 1 shared V. Kasim· 1 shared W. Duan· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

H. Zhao

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

YY2/BUB3 axis-mediated SAC hyperactivity determines tumor cell fate through chromosomal instability

R. Hosea, W. Duan, I. T. S. Meliala, W. Li, M. Wei, S. Hillary, H. Zhao, M. Miyagishi, S. Wu, V. Kasim

This study identifies the YY2/BUB3 axis as a regulator of SAC activity and shows how SAC hyperactivity and CIN levels influence tumor cell fate and drug sensitivity.

bioRxiv · Oct 7, 2023 · PreprintCancer Biology